Sun Pharma Advanced Research Company Limited (SPARC) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.336x

Based on the latest financial reports, Sun Pharma Advanced Research Company Limited (SPARC) has a cash flow conversion efficiency ratio of 0.336x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-1.16 Billion ≈ $-12.53 Million USD) by net assets (Rs-3.45 Billion ≈ $-37.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SPARC company net worth for the company's overall valuation and market capitalisation.

Sun Pharma Advanced Research Company Limited - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Sun Pharma Advanced Research Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sun Pharma Advanced Research Company Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sun Pharma Advanced Research Company Limited ranked by their cash flow conversion efficiency. Explore Sun Pharma Advanced Research Company Lim (SPARC) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Cogobuy Group
F:7C3
-0.057x
Turkiye Sinai Kalkinma Bankasi AS
IS:TSKB
0.071x
Danel (Adir Yeoshua) Ltd
TA:DANE
0.197x
Chin Hung Int'
KO:002780
0.211x
Hemnet Group AB
ST:HEM
0.154x
YaGuang Technology Group Co Ltd
SHE:300123
-0.035x
Inly Media Co Ltd
SHG:603598
-1.087x
Israel Shipyards Ltd
TA:ISHI
0.137x

Annual Cash Flow Conversion Efficiency for Sun Pharma Advanced Research Company Limited (2007–2025)

The table below shows the annual cash flow conversion efficiency of Sun Pharma Advanced Research Company Limited from 2007 to 2025. View Sun Pharma Advanced Research Company Lim (SPARC) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs-2.17 Billion
≈ $-23.46 Million
Rs-3.60 Billion
≈ $-38.96 Million
1.661x +148.66%
2024-03-31 Rs1.26 Billion
≈ $13.60 Million
Rs-4.29 Billion
≈ $-46.42 Million
-3.413x -2431.86%
2023-03-31 Rs5.13 Billion
≈ $55.45 Million
Rs-691.20 Million
≈ $-7.48 Million
-0.135x +97.98%
2022-03-31 Rs312.26 Million
≈ $3.38 Million
Rs-2.08 Billion
≈ $-22.52 Million
-6.669x -838.67%
2021-03-31 Rs-1.68 Billion
≈ $-18.20 Million
Rs-1.52 Billion
≈ $-16.43 Million
0.903x -92.02%
2020-03-31 Rs-186.38 Million
≈ $-2.02 Million
Rs-2.11 Billion
≈ $-22.80 Million
11.310x +2048.94%
2019-03-31 Rs2.96 Billion
≈ $32.04 Million
Rs-1.72 Billion
≈ $-18.59 Million
-0.580x +41.35%
2018-03-31 Rs1.85 Billion
≈ $19.98 Million
Rs-1.83 Billion
≈ $-19.77 Million
-0.989x -23.37%
2017-03-31 Rs1.60 Billion
≈ $17.27 Million
Rs-1.28 Billion
≈ $-13.85 Million
-0.802x +45.76%
2016-03-31 Rs299.03 Million
≈ $3.23 Million
Rs-442.12 Million
≈ $-4.78 Million
-1.479x -272.84%
2015-03-31 Rs997.99 Million
≈ $10.79 Million
Rs-395.76 Million
≈ $-4.28 Million
-0.397x -249.72%
2014-03-31 Rs1.39 Billion
≈ $15.06 Million
Rs368.95 Million
≈ $3.99 Million
0.265x +130.12%
2013-03-31 Rs1.08 Billion
≈ $11.73 Million
Rs-953.44 Million
≈ $-10.31 Million
-0.879x -184.34%
2012-03-31 Rs-666.09 Million
≈ $-7.20 Million
Rs-694.49 Million
≈ $-7.51 Million
1.043x +134.07%
2011-03-31 Rs56.23 Million
≈ $608.16K
Rs25.05 Million
≈ $270.90K
0.445x -50.20%
2010-03-31 Rs141.24 Million
≈ $1.53 Million
Rs126.34 Million
≈ $1.37 Million
0.895x +25.38%
2009-03-31 Rs356.78 Million
≈ $3.86 Million
Rs254.54 Million
≈ $2.75 Million
0.713x +256.80%
2008-03-31 Rs448.18 Million
≈ $4.85 Million
Rs-203.92 Million
≈ $-2.21 Million
-0.455x -54787.50%
2007-03-31 Rs497.01 Million
≈ $5.37 Million
Rs-412.00K
≈ $-4.46K
-0.001x --

About Sun Pharma Advanced Research Company Limited

NSE:SPARC India Drug Manufacturers - Specialty & Generic
Market Cap
$680.58 Million
Rs62.93 Billion INR
Market Cap Rank
#10797 Global
#542 in India
Share Price
Rs193.92
Change (1 day)
+0.39%
52-Week Range
Rs108.71 - Rs277.57
All Time High
Rs519.35
About

Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology and immunology. The company is also developing Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia th… Read more